Spoortz AS

Famweek AS

Spoortz Holding AS

DnB Handelsparker AS

Imove AS

DnB Private Equity IV (is) AS

DnB Livsforsikring AS

Lillebytunet AS

DnB Eiendomsutvikling AS

Vipps Holding AS

Fremtind Forsikring AS

Vipps Mobilepay AS

DnB Scandinavian Propfund AS

Traveltext AS

Nordic Mobility Services AS

DnB Private Equity i (gp) AS

Bøler Senter Næring AS

Falck Ytters Plass Eiendom AS

Amsc ASA

Norwegian Microfinance Initiative AS

Quantfolio AS

Koksa Eiendom AS

Abler Nordic Gp IV AS

Deltager AS

Abler Nordic AS

Contracting AS

Add Energy Group AS

Abl Group ASA

B2 Impact ASA

Dof Installer ASA

Endúr ASA

Dof Group ASA

Signord AS

Proventure Seed II AS

Alliance Venture Spring AS

Andfjord Salmon AS

Dof Subsea AS

Norsun AS

Argeo AS

DnB Bank ASA

Hexagon Purus ASA

Inin Group AS

Zi-Lift AS

Sparebanken Vest

Skagerak Capital III AS

Next Biometrics Group ASA

Brage Finans AS

Sarsia Seed Fond II AS

Berlin Topco AS

Berlin Midco AS

Dno ASA

Atlantic Sapphire ASA

Norwegian Air Shuttle ASA

Idex Biometrics ASA

Bergenbio ASA

Nykode Therapeutics ASA

Frank Maaø

Navn	Aksjetype	Ant aksjer	Andel
Spoortz Holding AS Org nr 920 930 271	Ordinære aksjer	20 000	0,161 %
Spoortz Holding AS Org nr 920 930 271 Aksjetype: Ordinære aksjer Ant aksjer: 20 000 Andel: 0,161 %
Nykode Therapeutics ASA Org nr 990 646 066		1 750	0,001 %
Nykode Therapeutics ASA Org nr 990 646 066 Ant aksjer: 1 750 Andel: 0,001 %
DnB Bank ASA Org nr 984 851 006		1 068	0 %
DnB Bank ASA Org nr 984 851 006 Ant aksjer: 1 068 Andel: 0 %

Frank Maaø

Aksjeposter

Vil du vite mer om hva Proff™ kan tilby din bedrift?

Din kontaktinfo